|
|
Meet the Lab |
|
Peter Haviernik, PhD
Peter Haviernik is an instructor in the Division of Hematology/Oncology, Department of Medicine at Case Western Reserve University School of Medicine. Dr. Haviernik joined the Laughlin lab in January of 2007. His previous work with Dr. Linda Wolff (Laboratory of Cellular Oncology, NCI-NIH) was aimed to study mechanism of leukemogenesis in c-myc and MML tumors in mice. Then, while working at Dr. Kevin Bunting’s lab (Division of Hematology/Oncology at CSCRM) he was studying role of TIMP/MMP balance in regulation of hematopoietic stem cell biology using mouse in vivo bone marrow transplant model.
His research is focused on short-term in vitro expansion of UCB HSC (CD133+) because its low content in UCB grafts limits rapid hematopoietic recovery of adult recipients after UCB transplantation. He is interested to elucidate mechanism by which BM derived MSC support multipotent more primitive state of HSC during cytokine-driven expansion.
|
|
|
|
|
PERSONNEL
Mary Laughlin, M.D.
(Principal Investigator)
Nick Greco, PhD
(Cardiology Project)
Jon Goldberg, MD
(Cardiology Project)
Mathew Lesniewski, PhD
(NFAT Project)
Peter Haviernik, PhD
(UCB Expansion Project)
Phil Paul, PhD
(UCB Expansion Project)
Margie Forster , MS
(Lab Manager, UCB Expansion Project)
Marcie Finney, MS
(Cardiology Project)
Laura Hammond , BS
(Multi-Cord and NK Project)
Pat Weitzel, BS
(NFAT project, Webmaster)
Yael Hegerfeldt, MD
(Leukemogenesis Project)
Paul Scheid
(Cardiology Project)
Aaron Victor
(Cardiology Project)
Karen Snyder, MEd
(Grants Administrator)
Nikhil Mohan
(Laboratory Assistant)
|
